BYSI Beyondspring Inc.

BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies.

$9.59  -0.39 (-3.91%)
As of 05/10/2021 16:00:01 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  Cayman Islands
IPO date:  03/09/2017
Outstanding shares:  39,141,913
Average volume:  154,193
Market cap:   $390,636,292
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    G10830100
ISIN:        KYG108301006
Sedol:      BD36JB9

---

Valuation   (See tab for details)

---

PE ratio:   -21.33
PB ratio:   4.25
PS ratio:   0.00
Return on equity:   -69.02%
Net income %:   -33,873.89%